This inventor holds 1 USPTO granted patent. Top assignees: Huawei Cloud Computing Technologies Co., Ltd., The First Affiliated Hospital of Xi'an Jiao Tong University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Denghui Liu
Introduction
Denghui Liu is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Denghui Liu holds a patent for the "Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection." This patent discloses the use of Belinostat or a pharmaceutically acceptable salt in the preparation of a drug aimed at treating infections. The patent also includes related methods and compositions that enhance the understanding and application of this treatment.
Career Highlights
Throughout his career, Denghui Liu has worked with prominent organizations, including Huawei Cloud Computing Technologies Co., Ltd. and The First Affiliated Hospital of Xi'an Jiao Tong University. His experience in these institutions has allowed him to collaborate with leading professionals in the field and contribute to groundbreaking research.
Collaborations
Denghui Liu has had the opportunity to work alongside talented individuals such as Bing Liu and Xin Wang. These collaborations have enriched his research and have played a crucial role in the development of his innovative ideas.
Conclusion
Denghui Liu's contributions to the field of pharmaceuticals, particularly through his patent on Belinostat, highlight his role as a significant inventor. His work not only showcases his innovative spirit but also emphasizes the importance of collaboration in advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile